The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study
PHASE2CompletedINTERVENTIONAL
Enrollment
216
Participants
Timeline
Start Date
December 31, 2014
Primary Completion Date
May 31, 2016
Study Completion Date
September 30, 2017
Conditions
Chronic Kidney DiseaseType 2 Diabetes
Interventions
DRUG
RTA 402
DRUG
Placebo
Trial Locations (1)
Unknown
Tokyo
All Listed Sponsors
lead
Kyowa Kirin Co., Ltd.
INDUSTRY
NCT02316821 - The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study | Biotech Hunter | Biotech Hunter